Synergy of BID with doxorubicin in the killing of cancer cells

Overexpression of the BH3-interacting domain death agonist (BID) protein sensitizes certain cancer cell lines to apoptosis induced by anticancer agents, particularly by those acting through death receptors (e.g. TRAIL). Previously, we showed that recombinant BID fused with TAT cell penetrating pepti...

Descripción completa

Detalles Bibliográficos
Autores principales: ORZECHOWSKA, EMILIA JOANNA, GIRSTUN, AGNIESZKA, STARON, KRZYSZTOF, TRZCINSKA-DANIELEWICZ, JOANNA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391587/
https://www.ncbi.nlm.nih.gov/pubmed/25760094
http://dx.doi.org/10.3892/or.2015.3841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391587/
https://www.ncbi.nlm.nih.gov/pubmed/25760094
http://dx.doi.org/10.3892/or.2015.3841

Ejemplares similares